An Evaluation of the Real-World Effectiveness of Immunoglobulin Therapy in Chronic Inflammatory Demyelinating Polyneuropathy. [PDF]
Hubsch A +8 more
europepmc +1 more source
Correction: Development of a PROM set for patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP): study protocol. [PDF]
Pelouto F +3 more
europepmc +1 more source
Epidemiology, Presentation, Management and Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy in Birmingham, UK: The Impact of Ethnicity. [PDF]
Rajabally Z +3 more
europepmc +1 more source
Chronic inflammatory demyelinating polyneuropathy
Frank Gaillard +2 more
openaire +2 more sources
Genetic and metabolic inflammation signatures in chronic inflammatory demyelinating polyneuropathy: the role of IL18 polymorphisms and short-chain fatty acids. [PDF]
Andrusiów S +7 more
europepmc +1 more source
Blood-Nerve Barrier Breakdown Induced by Immunoglobulin G in Typical and Multifocal Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy. [PDF]
Shimizu F +10 more
europepmc +1 more source
Subacute cutaneous lupus erythematosus secondary to intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy: A case report. [PDF]
Smith K, Nathoo R, Foss MG.
europepmc +1 more source
Real-World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape. [PDF]
Querol L +10 more
europepmc +1 more source
Very High Dose Immunoglobulin Treatment for Chronic Inflammatory Demyelinating Polyneuropathy: A Multicentre UK Study. [PDF]
Rajabally YA, Freiha J, Min YG, Osman C.
europepmc +1 more source

